Cargando…
Arginase II inhibitory activity of flavonoid compounds from Scutellaria indica
Arginase II has recently reported as a novel therapeutic target for the treatment of cardiovascular diseases such as atherosclerosis. In the course of screening plants used in natural medicines as arginase II inhibitory activity, a methanol extract of Scutellaria indica showed significant inhibitory...
Autores principales: | Kim, Sang Won, Cuong, To Dao, Hung, Tran Manh, Ryoo, Sungwoo, Lee, Jeong Hyung, Min, Byung Sun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3731522/ https://www.ncbi.nlm.nih.gov/pubmed/23604721 http://dx.doi.org/10.1007/s12272-013-0125-3 |
Ejemplares similares
-
Endothelial arginase II and atherosclerosis
por: Ryoo, Sungwoo, et al.
Publicado: (2011) -
Increased arginase II activity contributes to endothelial dysfunction through endothelial nitric oxide synthase uncoupling in aged mice
por: Shin, Woosung, et al.
Publicado: (2012) -
p32-Dependent p38 MAPK Activation by Arginase II Downregulation Contributes to Endothelial Nitric Oxide Synthase Activation in HUVECs
por: Koo, Bon-Hyeock, et al.
Publicado: (2020) -
Intravenous administration of piceatannol, an arginase inhibitor, improves endothelial dysfunction in aged mice
por: Nguyen, Minh Cong, et al.
Publicado: (2017) -
Arginase II protein regulates Parkin-dependent p32 degradation that contributes to Ca(2+)-dependent eNOS activation in endothelial cells
por: Koo, Bon-Hyeock, et al.
Publicado: (2021)